An open label, multicentre study of topiramate (topamax) as adjuctive therapy in patients with partial onset seizures with or without secondary generalisation, that are inadequately controlled
| dc.contributor.author | Dr Sussman, Paul | |
| dc.date.accessioned | 2018-06-05T13:23:49Z | |
| dc.date.available | 2018-06-05T13:23:49Z | |
| dc.date.issued | 2001-02 | |
| dc.description | A dissertation submitted to the Faculty of Medicine at the University of the Witwatersrand, Johannesburg for a degree Master of Science Medicine Pharmacotherapy | en_ZA |
| dc.description.abstract | Topiramate is an effective adjuctive anticonvulsant with a favourable safety profile. Topiramate is a sulphamate-substituted monosaccharide derived from D-fructose and is structurally unrelated to other anti-epileptic drugs .It is available in variable strength, tablet and sprinkle capsule formulations. It acts by multiple mechanisms that suggest it may be effective in sevsral types of epilepsy | en_ZA |
| dc.description.librarian | IT2018 | en_ZA |
| dc.identifier.uri | https://hdl.handle.net/10539/24602 | |
| dc.language.iso | en | en_ZA |
| dc.subject.mesh | Topiramate | |
| dc.subject.mesh | Seizures | |
| dc.subject.mesh | Anticonvulsants | |
| dc.title | An open label, multicentre study of topiramate (topamax) as adjuctive therapy in patients with partial onset seizures with or without secondary generalisation, that are inadequately controlled | en_ZA |
| dc.type | Thesis | en_ZA |